🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

TRACE 2 announced at #ISC2023 as positive. Chinese non-inferiority trial of TNK vs TPA in 1430 AIS pts w/in 4.5 h. thelancet.com/journals/lance…

Instructions on how to claim CME credits for #ISC2023 … in case like me, you can’t recall the them later

ANGEL ASPECT trial announced at #ISC2023. Chinese large core LVO (24 hr window). (No ASPECT >5 enrolled). Trial stopped early due to efficacy of MT (better 3 mo outcome) Trial of Endovascular Therapy for Acute Ischemic Stroke with Large Infarct | NEJM nejm.org/doi/full/10.10…

CATIS 2 announced at #ISC2023. Chinese Multicenter randomized open label blinded endpoint of early anti-HTN treatment vs delayed (day 7) in 4810 AIS patients (excluding IVT or MT). No difference in primary outcome (poor outcome at 90 day)

ARAMIS trial announced at #ISC2023. Chinese RCT of dAPT vs IVT in AIS minor deficits (NIHSS <=5) within 4.5h found that dAPT was noninferior to IVtPA.

SELECT2 Results presented at #ISC23

ANGEL-ASPECT Results presented at #ISC23 In this trial conducted in China, stroke patients with large infarct core treated with endovascular therapy had a better functional outcome at three months than medical management but had more intracranial hemorrhage.

RESCUE-BT2 Results presented at #ISC23

SELECT 2 trial announced at #ISC2023. Large core LVO (CT ASPECT 3-5, or CTP core >= 50mL) stopped early for efficacy of MT (associated with better functional outcome). Trial of Endovascular Thrombectomy for Large Ischemic Strokes | NEJM nejm.org/doi/full/10.10…

CMOSS trial announced at #ISC2023. Chinese trial AIS within 12 mo with ICA/MCA occlusion and hemodynamic insufficiency compared EC-IC bypass surgery vs medical. No sig. diff in Primary outcome (stroke/death 30 d or IS in territory w/in 2 y): 8.6% (surgery) vs 12.3% (MM), p 0.38

RESCUE BT2 trial announced at #ISC2023. In 1177 Chinese AIS pts without LVO/MeVO within 24 hrs, IV tirofiban associated with improved outcome (mRS 0-1 at 90 days) compared to Asa.

South Korea is a country run by older men. Below, a gathering of leaders and senior officials from national and local governments. Not a woman in sight.

The large core #stroke trials ANGEL-ASPECT Trial and #Select2 required CT ASPECT 3-5 OR CTP large core, but no patient was enrolled in either trial w/ASPECT > 6. There is a gap in RCT evidence for this subset. Curious to hear thoughts on this? #NeuroTwitter nejm.org/doi/full/10.10…

Congrats to Jessica Glenn on presenting her poster at #AANAM2023 on pediatric stroke thrombectomy The Ohio State University Wexner Medical Center @OSUNeuroInst #AANAM

Congrats to Nick and Elena on presenting their poster at #AANAM2023 on performance of Viz.AI in stroke care The Ohio State University Wexner Medical Center @OSUNeuroInst #AANAM

PSA- Hyatt Ziva Cancun stays do not give you 4x points when paying with hyatt branded Visa card. They do something sneaky and charge it as a travel agency (even if you book on their official website). So if staying at Hyatt Ziva- do NOT use WOH Visa card. The Points Guy

TRACE-III - a Chinese trial that showed benefit of IV TNK up to 24 hrs in LVO #stroke with favorable perfusion, who are not going to thrombectomy Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy | New England Journal of Medicine nejm.org/doi/full/10.10…

Editorial for TRACE -III Small Step or Giant Leap? Expanding the Acute Stroke Thrombolysis Window to 24 Hours | New England Journal of Medicine nejm.org/doi/full/10.10…

The @delta departures board @atlantaairport today

#Stroke and Neuro emergency Symposium. Friday Sept 13, 2024, 7a-5p, Toledo Zoo (virtual option available). Free registration for residents and med students #NeuroTwitter #MedEd #Neurology #MedTwitter eeds.com/portal_live_ev…